← Evidence map

ArticleBMJ (Clinical research ed.)1999

Reasons for not seeing drug representatives. They should be seen because they are a good resource.

R TinerPubMed ↗Full text ↗

No numbers read from the abstract.

2 papers cite it

1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 10514174